Register Login

BIO-TECHNE CORP (TECH)

Director Kelderman Kim 🟡 adjusted position in 724.3K shares (17 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($39.1M) Transaction Date: Apr 14, 2026 | Filing ID: 000070

Full text
Register to leave comments
  • News bot April 16, 2026, 8:20 p.m.

    🔍 Kelderman Kim (Director)

    Company: BIO-TECHNE Corp (TECH)

    Report Date: 2026-04-14

    Transaction Summary:

    • Total transactions: 19
    • Derivative instruments: 17
    • Holdings reported: 16
    • Total shares acquired: 36,500
    • Total shares sold: 68,588
    • Total shares held: 692,175

    Detailed Transactions and Holdings:

    • Acquired 36,500 shares of Common Stock (Direct)
      Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 85,165.00 | transaction_form_type: 4
    • Sold 32,088 shares of Common Stock at $58.66 per share (Direct)
      Date: 2026-04-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 53,077.00 | transaction_form_type: 4
    • Sold 36,500 shares of Stock Option (Right to Buy) at $47.6 per share (Derivative)
      Date: 2026-04-14 | Code: M | Expires: 2026-08-07 | equity_swap_involved: 0 | shares_owned_after: 73,036.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 115,724 shares of Stock Option (Right to Buy) at $66.97 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2027-08-05 | shares_owned_after: 115,724.00 | Footnotes: F1
    • Holds 25,944 shares of Stock Option (Right to Buy) at $120.46 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2028-08-06 | shares_owned_after: 25,944.00 | Footnotes: F1
    • Holds 28,940 shares of Stock Options (Right to Buy) at $94.52 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2029-08-15 | shares_owned_after: 28,940.00 | Footnotes: F1
    • Holds 8,873 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 8,873.00 | Footnotes: F2, F3, F3
    • Holds 23,881 shares of Performance Stock Options (Right to Buy) at $84.61 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2030-08-15 | shares_owned_after: 23,881.00 | Footnotes: F3
    • Holds 29,391 shares of Stock Options (Right to Buy) at $84.61 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2030-08-15 | shares_owned_after: 29,391.00 | Footnotes: F4
    • Holds 38,252 shares of Stock Options (Right to Buy) at $52.83 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2030-11-01 | shares_owned_after: 38,252.00 | Footnotes: F5
    • Holds 9,423 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 9,423.00 | Footnotes: F2, F3, F3
    • Holds 25,945 shares of Performance Stock Options (Right to Buy) at $68.54 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2031-02-01 | shares_owned_after: 25,945.00 | Footnotes: F3
    • Holds 51,890 shares of Stock Options (Right to Buy) at $68.54 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2031-02-01 | shares_owned_after: 51,890.00 | Footnotes: F6
    • Holds 51,261 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 51,261.00 | Footnotes: F2, F7, F7
    • Holds 17,087 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 17,087.00 | Footnotes: F2, F8, F8
    • Holds 69,061 shares of Stock Options (Right to Buy) at $74.91 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2034-08-15 | shares_owned_after: 69,061.00 | Footnotes: F9
    • Holds 70,708 shares of Performance Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 70,708.00 | Footnotes: F2, F10, F10
    • Holds 35,354 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-14 | Code: H | shares_owned_after: 35,354.00 | Footnotes: F2, F11, F11
    • Holds 90,441 shares of Stock Options (Right to Buy) at $53.6 per share (Derivative)
      Date: 2026-04-14 | Code: H | Expires: 2035-08-15 | shares_owned_after: 90,441.00 | Footnotes: F12

    Footnotes:

    • F1: Fully exercisable.
    • F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
    • F3: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
    • F4: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.
    • F5: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.
    • F6: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.
    • F7: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
    • F8: 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.
    • F9: Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.
    • F10: Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
    • F11: 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028.
    • F12: Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

Search

News categories